Taconic Biosciences Launches TruBIOME™ to Create Animal Models with Custom Microbiome Profiles
RENSSELAER, N.Y., April 15, 2019 (GLOBE NEWSWIRE) -- Taconic Biosciences, a global leader in providing genetically engineered rodent model solutions, announces the launch of TruBIOME
, a first of its kind solution enabling the generation and maintenance of mice with custom microbiome profiles.
TruBIOMETM was developed to meet the research community’s need for a microbiome solution that affords increased predictability, reproducibility, and systems biology insight within mouse model use. It is the first and only platform that allows researchers to develop models with customized microbiota profiles and then expand to produce study cohorts with similar microbiomes via natural mating, all while monitored with extensive quality controls.
The TruBIOMETM solution also includes the Taconic Microbiota Repository™, a collection of defined microbiome profiles. The collection currently includes the Wild Mouse gut microbiome licensed from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and Altered Schaedler Flora (ASF). Having defined microbiomes provides customers with a basis for comparison to better understand the microbiome of their research models.
The attrition rate of potential therapeutics is high on the path to becoming an approved drug, with over 90% of molecules discovered using traditional techniques failing in human clinical trials according to a recent article in Forbes . Scientists constantly pursue ways to improve these odds through the understanding and control of variables. The microbiome has been identified as a contributor to experimental variability. Researchers conducting microbiome studies and those pursuing general drug discovery need to better understand the microbiome’s impact. Understanding the microbiome will not only provide insight into potential confounding variables, but also could lead to identifying new drug targets.
“Decades of experience leading the industry in commercial germ-free mouse production, germ-free derivation, and gnotobiotic husbandry services provide Taconic with a strong foundation to enable customers to access the solutions they need to address microbiome research challenges,” expresses Nancy Sandy, chief executive officer at Taconic. “The launch of TruBIOMETM is exciting because it is gives researchers the ability to learn how microbial variability impacts their animal model experiments.”
To learn more about Taconic’s microbiome solutions portfolio, please call 1-888-TACONIC (888-822-6642 ) in the US, +45 70 23 04 05 in Europe, or email email@example.com .
About Taconic Biosciences, Inc.
Taconic Biosciences is a fully-licensed, global leader in genetically engineered rodent models and services. Founded in 1952, Taconic provides the best animal solutions so that customers can acquire, custom generate, breed, precondition, test, and distribute valuable research models worldwide. Specialists in genetically engineered mouse and rat models, precision research mouse models, and integrated model design and breeding services, Taconic operates three service laboratories and six breeding facilities in the U.S. and Europe, maintains distributor relationships in Asia and has global shipping capabilities to provide animal models almost anywhere in the world.
Kelly Owen Grover
Director of Marketing Communications
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Bizagi17.7.2019 18:02:02 CEST | Press release
Bizagi goes from Stealth to Hyper Growth Delivering Digital Transformation for World Leading Brands
Erytech Pharma S.A.16.7.2019 22:02:00 CEST | Press release
ERYTECH Pharma Reports Voting Results from Annual General Meeting Held on June 21, 2019
WSO215.7.2019 15:02:38 CEST | Press release
WSO2 Introduces WSO2 API Microgateway 3.0 to Simplify Creating, Deploying and Securing APIs in Microservice Environments
Lubrizol15.7.2019 08:01:33 CEST | Press release
Lubrizol Acquires Bavaria Medizin Technologie GmbH
PBSC Urban Solutions13.7.2019 00:03:47 CEST | Press release
H.S.H. PRINCE ALBERT II LAUNCHES MONABIKE, MONACO’S NEW FULLY-ELECTRIC BIKE SHARE FROM PBSC URBAN SOLUTIONS
Lubrizol11.7.2019 19:02:04 CEST | Press release
Lubrizol Integrates Personal, Home and Health Care Divisions; Now Lubrizol Life Science
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom